{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:04:01Z","timestamp":1790251441587,"version":"4.1.0"},"reference-count":44,"publisher":"Impact Journals, LLC","issue":"31","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,4,24]]},"DOI":"10.18632\/oncotarget.25164","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T15:34:10Z","timestamp":1524584050000},"page":"22220-22229","source":"Crossref","is-referenced-by-count":16,"title":["Sporadic renal angiomyolipoma in a patient with Birt-Hogg-Dub\u00e9: chaperones in pathogenesis"],"prefix":"10.18632","volume":"9","author":[{"given":"Rebecca A.","family":"Sager","sequence":"first","affiliation":[{"name":"Department of Urology, SUNY Upstate Medical University, Syracuse, NY, USA"},{"name":"Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY, USA"},{"name":"Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Woodford","sequence":"additional","affiliation":[{"name":"Department of Urology, SUNY Upstate Medical University, Syracuse, NY, USA"},{"name":"Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY, USA"},{"name":"Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Department of Urology, SUNY Upstate Medical University, Syracuse, NY, USA"},{"name":"Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Mollapour","sequence":"additional","affiliation":[{"name":"Department of Urology, SUNY Upstate Medical University, Syracuse, NY, USA"},{"name":"Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY, USA"},{"name":"Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennady","family":"Bratslavsky","sequence":"additional","affiliation":[{"name":"Department of Urology, SUNY Upstate Medical University, Syracuse, NY, USA"},{"name":"Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2018,4,24]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1086\/323744","article-title":"Birt-Hogg-Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2","volume":"69","author":"Greenberg","year":"2001","journal-title":"Am J Hum Genet"},{"key":"2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1535-6108(02)00104-6","article-title":"Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome","volume":"2","author":"Munroe","year":"2002","journal-title":"Cancer Cell"},{"key":"3","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nrurol.2015.206","article-title":"Molecular genetics and clinical features of Birt-Hogg-Dube syndrome","volume":"12","author":"Linehan","year":"2015","journal-title":"Nat Rev Urol"},{"key":"4","doi-asserted-by":"publisher","first-page":"15292","DOI":"10.18632\/oncotarget.7733","article-title":"Sixth BHD symposium and first international upstate kidney cancer symposium: latest scientific and clinical discoveries","volume":"7","author":"Mollapour","year":"2016","journal-title":"Oncotarget"},{"key":"5","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1001\/archderm.1977.01640120042005","article-title":"Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons","volume":"113","author":"Dube","year":"1977","journal-title":"Arch Dermatol"},{"key":"6","first-page":"393","article-title":"Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dube syndrome","volume":"11","author":"Greenberg","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"7","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/00000478-200212000-00002","article-title":"Renal tumors in the Birt-Hogg-Dube syndrome","volume":"26","author":"Merino","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"8","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1097\/01.ju.0000154629.45832.30","article-title":"Evaluation and management of renal tumors in the Birt-Hogg-Dube syndrome","volume":"173","author":"Linehan","year":"2005","journal-title":"J Urol"},{"key":"9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.juro.2010.10.068","article-title":"Renal oncocytosis: management and clinical outcomes","volume":"185","author":"Russo","year":"2011","journal-title":"J Urol"},{"key":"10","doi-asserted-by":"publisher","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex","volume":"2","author":"Thiele","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"11","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","author":"European Chromosome 16 Tuberous Sclerosis Consortium","year":"1993","journal-title":"Cell"},{"key":"12","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"Woodward","year":"1997","journal-title":"Science"},{"key":"13","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1002\/ajmg.a.37952","article-title":"Renal angiomyolipoma in Birt-Hogg-Dube syndrome: A case study supporting overlap with tuberous sclerosis complex","volume":"170","author":"Winship","year":"2016","journal-title":"Am J Med Genet A"},{"key":"14","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2169\/internalmedicine.51.7211","article-title":"Birt-Hogg-Dube syndrome with renal angiomyolipoma","volume":"51","author":"Seyama","year":"2012","journal-title":"Intern Med"},{"key":"15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1440-0960.2011.00738.x","article-title":"Birt-Hogg-Dube syndrome with a renal angiomyolipoma:further evidence of a relationship between Birt-Hogg-Dube syndrome and tuberous sclerosis complex","volume":"53","author":"Whittaker","year":"2012","journal-title":"Australas J Dermatol"},{"key":"16","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1016\/j.jaad.2004.11.021","article-title":"Multiple facial angiofibromas: a cutaneous manifestation of Birt-Hogg-Dube syndrome","volume":"53","author":"Dvoretzky","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"17","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/j.1365-2230.2008.03065.x","article-title":"Fibrofolliculoma in a patient with tuberous sclerosis complex","volume":"34","author":"Narisawa","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"18","doi-asserted-by":"publisher","first-page":"13571","DOI":"10.1073\/pnas.202476899","article-title":"Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling","volume":"99","author":"Blenis","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"19","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S1097-2765(03)00220-X","article-title":"Insulin activation of Rheb, a mediator of mTOR\/S6K\/4E-BP signaling, is inhibited by TSC1 and 2","volume":"11","author":"Thomas","year":"2003","journal-title":"Mol Cell"},{"key":"20","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0960-9822(03)00506-2","article-title":"Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb","volume":"13","author":"Blenis","year":"2003","journal-title":"Curr Biol"},{"key":"21","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.1038\/sj.onc.1204009","article-title":"The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination","volume":"19","author":"DeClue","year":"2000","journal-title":"Oncogene"},{"key":"22","doi-asserted-by":"publisher","first-page":"8313","DOI":"10.1074\/jbc.C500451200","article-title":"TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase","volume":"281","author":"Guan","year":"2006","journal-title":"J Biol Chem"},{"key":"23","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.15252\/embj.201796700","article-title":"Tumor suppressor Tsc1 is a new Hsp90 co-chaperone that facilitates folding of kinase and non-kinase clients","volume":"36","author":"Bourboulia","year":"2017","journal-title":"EMBO J"},{"key":"24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/jnci\/djm288","article-title":"Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1\/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys","volume":"100","author":"Ileva","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"25","doi-asserted-by":"publisher","first-page":"e3581","DOI":"10.1371\/journal.pone.0003581","article-title":"Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia","volume":"3","author":"Zhang","year":"2008","journal-title":"PLoS One"},{"key":"26","doi-asserted-by":"publisher","first-page":"18722","DOI":"10.1073\/pnas.0908853106","article-title":"Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2","volume":"106","author":"Linehan","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"27","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/onc.2009.14","article-title":"The role of the Birt-Hogg-Dube protein in mTOR activation and renal tumorigenesis","volume":"28","author":"Henske","year":"2009","journal-title":"Oncogene"},{"key":"28","doi-asserted-by":"publisher","first-page":"15552","DOI":"10.1073\/pnas.0603781103","article-title":"Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling","volume":"103","author":"Zhen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.gene.2008.02.022","article-title":"Identification and characterization of a novel folliculin-interacting protein FNIP2","volume":"415","author":"Schmidt","year":"2008","journal-title":"Gene"},{"key":"30","doi-asserted-by":"publisher","first-page":"12037","DOI":"10.1038\/ncomms12037","article-title":"The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug binding","volume":"7","author":"Bourboulia","year":"2016","journal-title":"Nat Commun"},{"key":"31","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrm.2017.20","article-title":"The HSP90 chaperone machinery","volume":"18","author":"Buchner","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"32","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.molcel.2017.08.004","article-title":"The Plasticity of the Hsp90 Co-chaperone System","volume":"67","author":"Buchner","year":"2017","journal-title":"Mol Cell"},{"key":"33","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1067\/mjd.2000.109288","article-title":"Parotid oncocytoma in the Birt-Hogg-Dube syndrome","volume":"43","author":"Page","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"34","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1086\/430842","article-title":"Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome","volume":"76","author":"Walther","year":"2005","journal-title":"Am J Hum Genet"},{"key":"35","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/jmg.2007.054304","article-title":"BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube syndrome: a new series of 50 families and a review of published reports","volume":"45","author":"Linehan","year":"2008","journal-title":"J Med Genet"},{"key":"36","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1399-0004.2010.01480.x","article-title":"Constitutional FLCN mutations in patients with suspected Birt-Hogg-Dube syndrome ascertained for non-cutaneous manifestations","volume":"79","author":"Genuardi","year":"2011","journal-title":"Clin Genet"},{"key":"37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1897-4287-10-13","article-title":"Birt-Hogg-Dube syndrome presenting as multiple oncocytic parotid tumors","volume":"10","author":"Pittelkow","year":"2012","journal-title":"Hered Cancer Clin Pract"},{"key":"38","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/ejhg.2013.8","article-title":"Where Birt-Hogg-Dube meets Cowden syndrome: mirrored genetic defects in two cases of syndromic oncocytic tumours","volume":"21","author":"Gasparre","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/gcc.2870130411","article-title":"Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas","volume":"13","author":"Kwiatkowski","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"40","doi-asserted-by":"publisher","first-page":"e24919","DOI":"10.1371\/journal.pone.0024919","article-title":"Angiomyolipoma have common mutations in TSC2 but no other common genetic events","volume":"6","author":"Kwiatkowski","year":"2011","journal-title":"PLoS One"},{"key":"41","doi-asserted-by":"publisher","first-page":"e1006242","DOI":"10.1371\/journal.pgen.1006242","article-title":"Whole Exome Sequencing Identifies TSC1\/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development","volume":"12","author":"Wu","year":"2016","journal-title":"PLoS Genet"},{"key":"42","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/S0140-6736(03)13044-9","article-title":"Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma","volume":"361","author":"Kwiatkowski","year":"2003","journal-title":"Lancet"},{"key":"43","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.humpath.2007.01.028","article-title":"Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms","volume":"38","author":"Yeung","year":"2007","journal-title":"Hum Pathol"},{"key":"44","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.celrep.2015.12.084","article-title":"Mps1 Mediated Phosphorylation of Hsp90 Confers Renal Cell Carcinoma Sensitivity and Selectivity to Hsp90 Inhibitors","volume":"14","author":"Tsutsumi","year":"2016","journal-title":"Cell Rep"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.25164","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T16:41:07Z","timestamp":1589042467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.25164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,24]]},"references-count":44,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2018,4,24]]}},"alternative-id":["25164","29774133"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.25164","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,24]]}}}